87 / 264
54. Quaranta A, Marini F, Sallustio V. Long-term outcome of Me´nie`re’s
disease: endolymphatic mastoid shunt versus natural history.
Audiol
Neurootol
1998;3:54
Y
60.
55. Arenberg IK. Endolymphatic sac valve implant surgery. III.
Preliminary results in 61 cases (66 ears).
Laryngoscope
1979;89
(7 Pt 2):26
Y
39.
56. Arenberg IK, Spector GJ. Endolymphatic sac surgery for hearing
conservation in Me´nie`re disease.
Arch Otolaryngol
1977;103:
268
Y
70.
57. Couloigner V, Teixeira M, Sterkers O, Rask-Andersen H, Ferrary E.
[The endolymphatic sac: its roles in the inner ear].
Med Sci (Paris)
2004;20:304
Y
10.
58. Tomiyama S, Harris JP. The role of the endolymphatic sac in inner
ear immunity.
Acta Otolaryngol
1987;103:182
Y
8.
59. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM.
Proinflammatory cytokine expression in the endolymphatic sac
during inner ear inflammation.
J Assoc Res Otolaryngol
2003;4:
139
Y
47.
60. Arnold W, Altermatt HJ. The significance of the human endolym-
phatic sac and its possible role in Me´nie`re’s disease.
Acta Otolaryngol
Suppl
1995;519:36
Y
42.
61. Derebery MJ. Allergic and immunologic aspects of Me´nie`re’s dis-
ease.
Otolaryngol Head Neck Surg
1996;114:360
Y
5.
62. Wackym PA, Friberg U, Linthicum FH Jr, et al. Human endolym-
phatic sac: morphologic evidence of immunologic function.
Ann
Otol Rhinol Laryngol
1987;96(3 Pt 1):276
Y
81.
63. Arnold W, Pfaltz R, Altermatt HJ. Evidence of serum antibodies
against inner ear tissues in the blood of patients with certain sen-
sorineural hearing disorders.
Acta Otolaryngol
1985;99:437
Y
44.
64. Soliman AM. A subpopulation of Me´nie`re’s patients produce
antibodies that bind to endolymphatic sac antigens.
Am J Otol
1996;17:76
Y
80.
65. Maekawa C, Kitahara T, Kizawa K, et al. Expression and translo-
cation of aquaporin-2 in the endolymphatic sac in patients with
Me´nie`re’s disease.
J Neuroendocrinol
2010;22:1157
Y
64.
66. Kitahara T, Maekawa C, Kizawa K, Horii A, Doi K. Plasma va-
sopressin and V2 receptor in the endolymphatic sac in patients with
delayed endolymphatic hydrops.
Otol Neurotol
2009;30:812
Y
9.
67. Taguchi D, Takeda T, Kakigi A, Takumida M, Nishioka R, Kitano
H. Expressions of aquaporin-2, vasopressin type 2 receptor, tran-
sient receptor potential channel vanilloid (TRPV) 1, and TRPV4 in
the human endolymphatic sac.
Laryngoscope
2007;117:695
Y
8.
68. Kakigi A, Nishimura M, Takeda T, Taguchi D, Nishioka R. Ex-
pression of aquaporin1, 3, and 4, NKCC1, and NKCC2 in the
human endolymphatic sac.
Auris Nasus Larynx
2009;36:135
Y
9.
69. Hallpike CS, Cairns H. Observations on the pathology of Me´nie`re’s
syndrome: (section of otology).
Proc R Soc Med
1938;31:1317
Y
36.
70. Light JP, Silverstein H. Transtympanic perfusion: indications and
limitations.
Curr Opin Otolaryngol Head Neck Surg
2004;12:
378
Y
83.
71. Arenberg IK. Endolymphatic sac valve implant surgery. V. Expe-
riences with reporting results of treatment in Me´nie`re’s disease.
Laryngoscope
1979;89(7 Pt 2):48
Y
53.
72. Thomsen J, Bretlau P, Tos M, Johnsen NJ. Placebo effect in sur-
gery for Me´nie`re’s disease. A double-blind, placebo-controlled
study on endolymphatic sac shunt surgery.
Arch Otolaryngol
1981;
107:271
Y
7.
73. Pillsbury HC 3rd, Arenberg IK, Ferraro J, Ackley RS. Endolym-
phatic sac surgery. The Danish sham surgery study: an alternative
analysis.
Otolaryngol Clin North Am
1983;16:123
Y
7.
74. Smith WC, Pillsbury HC. Surgical treatment of Me´nie`re’s disease
since Thomsen.
Am J Otol
1988;9:39
Y
43.
75. Arenberg IK. Placebo effect for Me´nie`re’s disease sac shunt surgery
disputed.
Arch Otolaryngol
1981;107:773
Y
4.
76. Welling DB, Nagaraja HN. Endolymphatic mastoid shunt: a
reevaluation of efficacy.
Otolaryngol Head Neck Surg
2000;
122:340
Y
5.
77. Arenberg IK, Newkirk JB, Stahle J. Endolymphatic sac valve
implant surgery. II: The unidirectional inner ear valve implant.
Laryngoscope
1979;89(7 Pt 2):21
Y
5.
78. Arenberg IK, Balkany TJ. Revision endolymphatic sac and duct
surgery for recurrent Me´nie`re’s disease and hydrops: failure anal-
ysis and technical aspects.
Laryngoscope
1982;92:1279
Y
84.
79. Goin DW, Mischke RE, Esses BA, Young D, Priest EA,
Whitmoyer-Goin V. Hearing results from endolymphatic sac sur-
gery.
Am J Otol
1992;13:393
Y
7.
80. Paparella MM. Endolymphatic sac revision for recurrent intractable
Me´nie`re’s disease.
Otolaryngol Clin North Am
2006;39:713
Y
21, vi.
81. Paparella MM. Revision of endolymphatic sac surgery for recur-
rent Me´nie`re’s disease.
Otolaryngol Clin North Am
2002;35:
607
Y
19, viii.
82. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for
Me´nie`re’s disease.
Otolaryngol Head Neck Surg
1989;100:6
Y
16.
ENDOLYMPHATIC SAC SURGERY FOR ME´ NIE` RE
_
S DISEASE
Otology & Neurotology, Vol. 35, No. 6, 2014
66